GE HealthCare Technologies Net Income
| GEHC Stock | 79.22 0.14 0.18% |
As of the 11th of February 2026, GE HealthCare owns the Market Risk Adjusted Performance of 0.0764, semi deviation of 1.74, and Standard Deviation of 1.89. GE HealthCare Technologies technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.
GE HealthCare Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.0716 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 2.2 B | 2.2 B | |
| Net Income Applicable To Common Shares | 1.7 B | 1.6 B | |
| Net Income | 2.2 B | 2.2 B | |
| Net Income Per Share | 3.68 | 3.50 | |
| Net Income Per E B T | 0.78 | 1.51 |
GEHC | Net Income | Build AI portfolio with GEHC Stock |
Analyzing GE HealthCare's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing GE HealthCare's current valuation and future prospects.
Latest GE HealthCare's Net Income Growth Pattern
Below is the plot of the Net Income of GE HealthCare Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in GE HealthCare Techno financial statement analysis. It represents the amount of money remaining after all of GE HealthCare Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is GE HealthCare's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GE HealthCare's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 2.15 B | 10 Years Trend |
|
Net Income |
| Timeline |
GEHC Net Income Regression Statistics
| Arithmetic Mean | 2,557,825,210 | |
| Geometric Mean | 2,022,534,285 | |
| Coefficient Of Variation | 115.53 | |
| Mean Deviation | 1,450,535,640 | |
| Median | 1,524,000,000 | |
| Standard Deviation | 2,954,937,169 | |
| Sample Variance | 8731653.7T | |
| Range | 12.3B | |
| R-Value | 0.23 | |
| Mean Square Error | 8815029.2T | |
| R-Squared | 0.05 | |
| Significance | 0.37 | |
| Slope | 135,409,874 | |
| Total Sum of Squares | 139706458.8T |
GEHC Net Income History
Other Fundumenentals of GE HealthCare Techno
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
GE HealthCare Net Income component correlations
GEHC Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for GE HealthCare is extremely important. It helps to project a fair market value of GEHC Stock properly, considering its historical fundamentals such as Net Income. Since GE HealthCare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GE HealthCare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GE HealthCare's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could GEHC diversify its offerings? Factors like these will boost the valuation of GE HealthCare. Market participants price GEHC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every GE HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.18) | Dividend Share 0.14 | Earnings Share 4.55 | Revenue Per Share | Quarterly Revenue Growth 0.071 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GE HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
GE HealthCare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GE HealthCare's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GE HealthCare.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in GE HealthCare on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding GE HealthCare Technologies or generate 0.0% return on investment in GE HealthCare over 90 days. GE HealthCare is related to or competes with Humana, IQVIA Holdings, Cardinal Health, Insmed, Alcon AG, BeiGene, and ResMed. GE HealthCare is entity of United States More
GE HealthCare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GE HealthCare's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GE HealthCare Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.86 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 7.77 | |||
| Value At Risk | (2.77) | |||
| Potential Upside | 3.38 |
GE HealthCare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GE HealthCare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GE HealthCare's standard deviation. In reality, there are many statistical measures that can use GE HealthCare historical prices to predict the future GE HealthCare's volatility.| Risk Adjusted Performance | 0.0434 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0664 |
GE HealthCare February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0434 | |||
| Market Risk Adjusted Performance | 0.0764 | |||
| Mean Deviation | 1.49 | |||
| Semi Deviation | 1.74 | |||
| Downside Deviation | 1.86 | |||
| Coefficient Of Variation | 2128.24 | |||
| Standard Deviation | 1.89 | |||
| Variance | 3.57 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0664 | |||
| Maximum Drawdown | 7.77 | |||
| Value At Risk | (2.77) | |||
| Potential Upside | 3.38 | |||
| Downside Variance | 3.45 | |||
| Semi Variance | 3.03 | |||
| Expected Short fall | (1.49) | |||
| Skewness | 0.2446 | |||
| Kurtosis | (0.26) |
GE HealthCare Techno Backtested Returns
At this point, GE HealthCare is very steady. GE HealthCare Techno retains Efficiency (Sharpe Ratio) of 0.0691, which attests that the entity had a 0.0691 % return per unit of price deviation over the last 3 months. We have found twenty-eight technical indicators for GE HealthCare, which you can use to evaluate the volatility of the firm. Please check out GE HealthCare's Standard Deviation of 1.89, market risk adjusted performance of 0.0764, and Semi Deviation of 1.74 to validate if the risk estimate we provide is consistent with the expected return of 0.13%. GE HealthCare has a performance score of 5 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 1.19, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GE HealthCare will likely underperform. GE HealthCare Techno today owns a risk of 1.93%. Please check out GE HealthCare Technologies sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to decide if GE HealthCare Technologies will be following its current price history.
Auto-correlation | -0.54 |
Good reverse predictability
GE HealthCare Technologies has good reverse predictability. Overlapping area represents the amount of predictability between GE HealthCare time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GE HealthCare Techno price movement. The serial correlation of -0.54 indicates that about 54.0% of current GE HealthCare price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.54 | |
| Spearman Rank Test | -0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 7.88 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
GEHC Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, GE HealthCare Technologies reported net income of 2.15 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is significantly lower than that of the firm.
GEHC Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GE HealthCare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GE HealthCare could also be used in its relative valuation, which is a method of valuing GE HealthCare by comparing valuation metrics of similar companies.GE HealthCare is currently under evaluation in net income category among its peers.
GE HealthCare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GE HealthCare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GE HealthCare's managers, analysts, and investors.Environmental | Governance | Social |
GEHC Fundamentals
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0547 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 42.73 B | ||||
| Shares Outstanding | 455.75 M | ||||
| Shares Owned By Insiders | 0.27 % | ||||
| Shares Owned By Institutions | 89.51 % | ||||
| Number Of Shares Shorted | 10.8 M | ||||
| Price To Book | 3.54 X | ||||
| Price To Sales | 1.75 X | ||||
| Revenue | 20.62 B | ||||
| Gross Profit | 8.25 B | ||||
| EBITDA | 3.79 B | ||||
| Net Income | 2.15 B | ||||
| Total Debt | 10 B | ||||
| Book Value Per Share | 22.77 X | ||||
| Cash Flow From Operations | 1.99 B | ||||
| Short Ratio | 3.86 X | ||||
| Earnings Per Share | 4.55 X | ||||
| Price To Earnings To Growth | 2.26 X | ||||
| Target Price | 93.25 | ||||
| Number Of Employees | 54 K | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 36.04 B | ||||
| Total Asset | 36.91 B | ||||
| Retained Earnings | 5.28 B | ||||
| Working Capital | 3.4 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 36.91 B | ||||
| Last Dividend Paid | 0.14 |
About GE HealthCare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GE HealthCare Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GE HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GE HealthCare Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:Check out You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Will Health Care Equipment & Supplies sector continue expanding? Could GEHC diversify its offerings? Factors like these will boost the valuation of GE HealthCare. Market participants price GEHC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every GE HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.18) | Dividend Share 0.14 | Earnings Share 4.55 | Revenue Per Share | Quarterly Revenue Growth 0.071 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GE HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.